NCT06997822 Integrated Recovery Program for Critical Illness
| NCT ID | NCT06997822 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | ICU Survivors |
| Study Type | INTERVENTIONAL |
| Enrollment | 240 participants |
| Start Date | 2025-11-03 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 240 participants in total. It began in 2025-11-03 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to investigate the effects of the Integrated Critical Illness Aftercare and Recovery Enhancement (I-CARE) program on reducing healthcare burden and improving functional outcomes in ICU survivors. The I-CARE program combines remote support via LINE Bot Care with in-person post-ICU recovery clinic visits. The study will assess whether this integrated care model reduces unplanned hospital readmissions and emergency department visits within six months after discharge, and improves physical and cognitive outcomes at 3 and 6 months post-discharge. Additionally, the study will evaluate the impact of a built-in patient-nurse interaction feature on ICU nurses' burnout and intention to leave, measured every six months over a two-year period.
Eligibility Criteria
Inclusion Criteria: * ICU survivors who had experienced endotracheal intubation and mechanical ventilation treatment. Exclusion Criteria: * ICU survivors who are unable to walk independently before admission * ICU survivors who are unable to receive assessment (e.g., dementia or mental retardation) * ICU survivors who don't have a smartphone. * ICU survivors were discharged to institutional care facilities
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06997822 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ICU Survivors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06997822 currently recruiting?
Yes, NCT06997822 is actively recruiting participants. Contact the research team at cherylchen@ntu.edu.tw for enrollment information.
Where is the NCT06997822 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06997822 clinical trial?
NCT06997822 is sponsored by National Taiwan University Hospital. The trial plans to enroll 240 participants.